Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
.National Taiwan University / 國立臺灣大學
Project / 研究計畫
Empirical Evaluation of Drug Reimbursement in the National Health Insurance System: Use of Granulocyte Colony-Stimulating Factor in Cancer Patients
Empirical Evaluation of Drug Reimbursement in the National Health Insurance System: Use of Granulocyte Colony-Stimulating Factor in Cancer Patients
Details
Primary Data
Project title
運用臨床實證評估全民健康保險藥品給付制度:以顆粒性白血球生長刺激素於癌症病患之使用為例
Internal ID
NSC102-2410-H002-058-MY2
Principal Investigator
FEI-YUAN HSIAO
Start Date
August 1, 2013
End Date
July 12, 2014
Partner Organizations
National Science and Technology Council
Description
Keywords
癌症(cancer)
嗜中性白血球低下(neutropenia)
嗜中性白血球低下合併發燒 (febrile neutropenia
FN)
顆粒性白血球生長刺激素(granulocyte colony-stimulating factor
G-CSF)
流行病學(epidemiology)
處方型態(utilization pattern)
經濟效益評估 (cost-effectiveness)
全民健康保險(National Health Insurance system)
neutropenia
febrile neutropenia (FN)
granulocyte colony-stimulating factor (G-CSF)
epidemiology
utilization pattern
cost-effectiveness